We report the seminal experimental isolation and DFT characterization of pristine [5,5] C-D(1) fullertubes. This achievement represents the largest soluble carbon molecule obtained in its pristine form. The [5,5] C species is the highest aspect ratio fullertube purified to date and now surpasses the recent gigantic [5,5] C-D(1). In contrast to C, C, and C fullertubes, the longer C-D has nanotubular carbons (70) than end-cap fullerenyl atoms (60). Starting from 39,393 possible C isolated pentagon rule (IPR) structures and after analyzing polarizability, retention time, and UV-vis spectra, these three layers of data remarkably predict a single candidate isomer and fullertube, [5,5] C-D(1). This structural assignment is augmented by atomic resolution STEM data showing distinctive and tubular "pill-like" structures with diameters and aspect ratios consistent with [5,5] C-D(1) fullertubes. The high selectivity of the aminopropanol reaction with spheroidal fullerenes permits facile separation and removal of fullertubes from soot extracts. Experimental analyses (HPLC retention time, UV-vis, and STEM) were synergistically used (with polarizability and DFT property calculations) to down select and confirm the C fullertube structure. Achieving the isolation of a new [5,5] C-D fullertube opens the door to application development and fundamental studies of electron confinement, fluorescence, and metallic character for a fullertube series of molecules with systematic tubular elongation. This [5,5] fullertube family also invites comparative studies with single-walled carbon nanotubes (SWCNTs), nanohorns (SWCNHs), and fullerenes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jacs.3c09082 | DOI Listing |
Gynecol Oncol
November 2024
NYU Langone Health, New York, NY, USA.
Background: We evaluated the feasibility of completing 6 cycles of nab-paclitaxel (nab-P) and carboplatin (C) in a single arm prospective clinical trial for advanced/recurrent EC and safety and efficacy of day (D) 1, 8 nab-P in combination with D1 C q3weeks.
Methods: Patients with early-stage, high-risk, advanced primary/recurrent EC without prior platinum/taxane exposure were enrolled in an open-label, single-institution trial (NCT02744898). Patients received 6 cycles of D1 nab-P 100 mg/m IV with C AUC 6 IV and D8 nab-P 100 mg/m IV q21D.
Zhonghua Liu Xing Bing Xue Za Zhi
May 2023
National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
To understand the distribution of genotypes and sub-genotypes of HBV in different ethnic groups in China. The HBsAg positive samples were selected by stratified multi-stage cluster sampling from the sample base of national HBV sero-epidemiological survey in 2020 for the amplification of S gene of HBV by nested PCR. A phylogeny tree was constructed to determine the genotypes and sub-genotypes of HBV.
View Article and Find Full Text PDFNeurosci Res
July 2010
Division of Neuroscience, School of Biological Sciences, University of Manchester, Manchester M13 9PT, UK.
The ability of l-3,4-dihydroxyphenylalanine (l-DOPA), l-DOPA-methyl ester and their major metabolites, dopamine, dihydroxyphenylacetic acid (DOPAC), homovanillic (HVA), 3-O-methyldopa and 3-methoxytyramine (3-MT) to bind to alpha(2) adrenergic and D1 and D2 dopamine receptors was assessed by radioligand binding to cloned human receptors expressed in cell lines. As anticipated, dopamine bound with high affinity to D1 (IC(50) 1.1 + or - 0.
View Article and Find Full Text PDFBMC Cancer
September 2008
Cancer Genetics Program, Departments of Human Genetics and Oncology, Sir M.B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Background: Fanconi anemia (FA) is an autosomal recessive DNA repair disorder with affected individuals having a high risk of developing acute myeloid leukaemia and certain solid tumours. Thirteen complementation groups have been identified and the genes for all of these are known (FANCA, B, C, D1/BRCA2, D2, E, F, G, I, J/BRIP1, L, M and N/PALB2). Previous studies of cancer incidence in relatives of Fanconi anemia cases have produced conflicting results.
View Article and Find Full Text PDFTransplantation
April 1993
Immunobiology Laboratories, Massachusetts General Hospital, Charlestown 02129.
Donor graft major histocompatibility complex class I antigens are targets for both allogeneic and xenogeneic rejection. Mice homozygous for beta 2-microglobulin gene disruption express reduced amounts of surface MHC class I antigens. Liver cells from such mutant mice were transplanted into isogeneic, allogeneic, and xenogeneic recipients to evaluate the potential of these animals as transplant donors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!